• Info
  • Insider Ownership

Insider Trading & Ownership of Richard E. Lowenthal

Location
San Diego, CA
Summary
The estimated net worth of Richard E. Lowenthal is at least $202,790,460 dollars as of 05 Jan 2026. Richard E. Lowenthal is the PRESIDENT AND CEO, Director, 10%+ Owner of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $202.79M.
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Richard E. Lowenthal and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Richard E. Lowenthal has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $202,790,460.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ARS Pharmaceuticals, Inc. ($202,790,460).
  • Past-year value change for that position: -$724,345.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Richard E. Lowenthal

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRY ARS Pharmaceuticals, Inc. PRESIDENT AND CEO, Director, 10%+ Owner $202,790,460 -$724,345 -0.36% 02 Jan 2026

Insider Transactions Reported by Richard E. Lowenthal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored